836620-48-5
836620-48-5
Chemical Structure
AS1842856
- CAS No.: 836620-48-5
- Formula:C18H22FN3O3
- Molecular Weight:347.38
IUPAC Name: 5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
InChIKey: MOMCHYGXXYBDCD-UHFFFAOYSA-N
SMILES: O=C(C1=CN(CC)C2=C(C(N)=C(F)C(NC3CCCCC3)=C2)C1=O)O
Biological Activity: AS1842856, a specific Foxo1 inhibitor (IC50=30 nM), potently suppresses autophagy[1]. AS1842856 reduces Foxo1 activity and, to a lesser extent, inhibits Foxo1 protein expression by simply binding to Foxo1[2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AS1842856 | 99.88% | AS1842856, a specific Foxo1 inhibitor (IC50=30 nM), potently suppresses autophagy. AS1842856 reduces Foxo1 activity and, to a lesser extent, inhibits Foxo1 protein expression by simply binding to Foxo1. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
AS1842856 (GMP) | AS1842856 (GMP) is AS1842856 (HY-100596) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. AS1842856, a specific Foxo1 inhibitor (IC50=30 nM), potently suppresses autophagy. AS1842856 reduces Foxo1 activity and, to a lesser extent, inhibits Foxo1 protein expression by simply binding to Foxo1. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
AS1842856 (Standard) | 98.62% | AS1842856 (Standard) is the analytical standard of AS1842856 (HY-100596). This product is intended for research and analytical applications. AS1842856, a specific Foxo1 inhibitor (IC50=30 nM), potently suppresses autophagy. AS1842856 reduces Foxo1 activity and, to a lesser extent, inhibits Foxo1 protein expression by simply binding to Foxo1. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.59
HY-B0132RNorfloxacin (Standard) -
Similarity Score 0.58
HY-B0132ANorfloxacin hydrochloride -
Similarity Score 0.58
HY-B0147Pefloxacin -
Similarity Score 0.58
HY-119879Binfloxacin -
Similarity Score 0.58
HY-Z11315Ciprofloxacin impurity 1 -
Similarity Score 0.58
HY-122139RDesethylene Ciprofloxacin hydrochloride (Standard) -
Similarity Score 0.57
HY-B0147S1Pefloxacin-d3 -
Similarity Score 0.57
HY-138621Antibacterial agent 19 -
Similarity Score 0.57
HY-W780694PD 124816 -
Explore the MedChemAI to find more analogs
References
- [1]. Nagashima T, et al. Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice. Mol Pharmacol. 2010 Nov;78(5):961-70. [Content Brief]
- [2]. He J, et al. The resistant effect of SIRT1 in oxidative stress-induced senescence of rat nucleus pulposus cell is regulated by Akt-FoxO1 pathway. Biosci Rep. 2019 May 10;39(5). pii: BSR20190112. [Content Brief]
